杭州解百(600814.SH)擬出資100萬元共同設立宏逸聚信
格隆匯11月14日丨杭州解百(600814.SH)公佈,公司擬與中信聚信(北京)資本管理有限公司、杭州宏逸投資集團有限公司和杭州商旅金融投資有限公司共同發起設立宏逸聚信投資基金管理有限公司(以下簡稱“宏逸聚信”,暫名,最終以市場監督管理部門核准登記註冊名稱為準),宏逸聚信註冊資本1000萬元,公司投資100萬元,佔10%股權。
投資目的是以公司“零售+”戰略為引領,通過上市公司平台嫁接多方資源,促進外部資源的對接及與自有業務發展的有效融合,實現“零售+”產業佈局,獲得業務、品牌和價值提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.